Answers are grounded in this paper and cite their sources.
Demonstrates accurate meropenem analysis in human plasma, suggesting clinical utility.
Meropenem is a beta‐lactam antimicrobial that is used to treat severe infections. Critically ill patients are highly prone to pharmacokinetics variability and a fluctuation in meropenem plasma concentrations. The aim of this study is to provide a simple, rapid, precise and accurate method for the analysis of meropenem in human plasma using high‐performance liquid chromatography. Sample preparation involved a single step deproteinization of plasma (0.2 mL) using cold methanol in a 2:1 ratio. Chromatographic separation was achieved on a C18 column using a mobile phase of 50 mM phosphate buffer (pH 6.5) and acetonitrile (90:10, vol/vol) at a flow rate of 1 mL/min, with a total run time of 15 min. Ultraviolet detection was performed at 300 nm for meropenem and 254 nm for caffeine (internal standard). The method demonstrated excellent linearity over the range of 0.5–100 mg/L (r 2 > 0.99) with inter‐ and intra‐day precision and accuracy within acceptable limits. Finally, environmental impact assessment using various greenness tools confirmed the method's sustainability. The developed method is a simple, rapid and accurate method that could be utilized for research and therapeutic drug monitoring purposes to measure meropenem concentrations in human plasma.
No takes yet. Share an insight, caveat, or question.
Aboelezz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: